In one of the most high profile bidding wars of recent weeks, Legendary has emerged victorious in its battle to obtain rights to “Bad Blood.” The film is set to star Jennifer Lawrence as Elizabeth Holmes, the founder of the embattled blood testing company Theranos.
When news broke that Lawrence would star and Adam McKay (“The Big Short”) was to direct and write for the film, studios scrambled to nab the project, which is sure to be pure Oscar bait. “The Big Short” erupted into the awards race last December, and ultimately nabbed five Oscar nominations (winning one for Best Adapted Screenplay). Lawrence has four total nominations and one win for Best Actress for her role in “Silver Linings Playbook.”
Theranos’ highly publicized fall from grace should make for an interesting story. The company, which was once valued at $9 billion, most recently saw its value plummet when it was announced that the company was being investigated for inaccurate testing at one of its labs.
The Hollywood Reporter reports that Universal is distributing via their deal with Legendary. McKay, Will Ferrell, Kevin Messick and Lawrence are all producing.
The project is another buzzy one for Lawrence, who most recently starred in “X-Men: Apocalypse.” She also has Steven Spielberg’s “It’s What I Do” coming down the pipelines. In addition, she has Darren Aronofsky’s latest interesting project, “Mother,” with Domhnall Gleeson and Michelle Pfeiffer, as well as Morten Tyldum’s (“The Imitation Game”) space drama “Passengers” alongside Chris Pratt. Both “Mother” and “Passengers” are slated for awards season release dates in Dec. 2017 and 2016, respectively.